CNTX
Context Therapeutics Inc.Company Information
- Company Name
- Context Therapeutics Inc.
- CIK
- CIK0001842952
- Category
- <br>Emerging growth company
- Ticker: Exchange
- CNTX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CNTX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-09
- Last sale
- —
- Shares purchased (TTM)
- 160,010
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 61,768,256
- Shares outstanding
- 95,183,718
- Ownership
- 64.89%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -44.59%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 43 | 55 | 66 | 77 | 84 | 89 | 94 | 85 | 102 | 10 | 14 | 22 | ||||||
| Prepaid Expense And Other Assets Current | 3 | 4 | 2 | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | ||||||
| Assets Current | 46 | 59 | 68 | 79 | 87 | 93 | 98 | 86 | 103 | 11 | 16 | 23 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | ||||||
| Assets | 46 | 59 | 68 | 79 | 87 | 93 | 98 | 86 | 103 | 11 | 16 | 23 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Accrued Liabilities Current | 4 | 4 | 5 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | ||||||
| Liabilities Current | 8 | 7 | 8 | 6 | 5 | 2 | 3 | 2 | 2 | 3 | 4 | 5 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Liabilities | 8 | 7 | 8 | 6 | 5 | 2 | 3 | 2 | 2 | 3 | 4 | 5 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 192 | 192 | 191 | 191 | 191 | 190 | 190 | 175 | 175 | 80 | 80 | 80 | ||||||
| Retained Earnings Accumulated Deficit | -154 | -140 | -131 | -118 | -108 | -99 | -95 | -91 | -74 | -72 | -68 | -61 | ||||||
| Stockholders Equity | 38 | 52 | 60 | 73 | 83 | 91 | 95 | 84 | 101 | 8 | 12 | 18 | ||||||
| Liabilities And Stockholders Equity | 46 | 59 | 68 | 79 | 87 | 93 | 98 | 86 | 103 | 11 | 16 | 23 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 200 | 200 | 200 | 200 | 200 | 200 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 92 | 92 | 92 | 92 | 90 | 90 | 90 | 75 | 75 | 16 | 16 | 16 | ||||||
| Shares Outstanding | 92 | 92 | 92 | 92 | 90 | 90 | 90 | 75 | 75 | 16 | 16 | 16 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialContext Therapeutics Inc. (CNTX) — SEC Financial Statements & Analysis
Context Therapeutics Inc. (CNTX) is a pharmaceutical preparations company, incorporated in DE. Context Therapeutics Inc. trades on Nasdaq as: CNTX. Context Therapeutics Inc. (CNTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Context Therapeutics Inc. carries a market cap of $52.73M, a P/E ratio of -1.15x, a P/B ratio of 1.38x, an enterprise value of $9.74M, and an EV/EBITDA multiple of -0.20x. On profitability, it posts a Return on Equity (ROE) of -76.14% and a Return on Assets (ROA) of -68.96%. Per share, it reports EPS of $-0.48, diluted EPS of $-0.48, free cash flow per share of $-0.36, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 34.35% year-over-year and EPS growth of 34.35% year-over-year. On the balance sheet, it maintains a current ratio of 5.81x, a quick ratio of 5.45x, working capital of $37.93M, a debt-to-equity ratio of 0.21x, a debt ratio of 0.17, an interest coverage ratio of -30.80x, free cash flow of $-34.03M (TTM), and net debt of $-42.99M. Figures sourced from SEC EDGAR.
- Market Cap
- $52.73M
- P/E TTM
- -1.15x
- EPS TTM
- $-0.48
- P/B TTM
- 1.38x
- ROE TTM
- -76.14%
- ROA TTM
- -68.96%
- Debt To Equity
- 0.21x
- Free Cash Flow TTM
- $-34.03M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Context Therapeutics Inc. in?
Context Therapeutics Inc. (CNTX) operates in the Pharmaceutical Preparations industry.
What exchange does CNTX trade on?
Context Therapeutics Inc. (CNTX) trades on the Nasdaq.
Where is Context Therapeutics Inc. incorporated?
Context Therapeutics Inc. is incorporated in DE.
When was Context Therapeutics Inc. (CNTX)'s most recent SEC filing?
Context Therapeutics Inc. (CNTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is CNTX's market cap?
Context Therapeutics Inc. (CNTX) has a market capitalization of $52.73M as of 2026-06-30.
What is CNTX's EPS (earnings per share)?
Context Therapeutics Inc. (CNTX)'s trailing twelve month EPS is $-0.48 as of 2026-06-30.
What is CNTX's ROE (return on equity)?
Context Therapeutics Inc. (CNTX)'s trailing twelve month Return on Equity (ROE) is -76.14% as of 2026-06-30.
What is CNTX's ROA (return on assets)?
Context Therapeutics Inc. (CNTX)'s trailing twelve month Return on Assets (ROA) is -68.96% as of 2026-06-30.
What is CNTX's EV/EBITDA?
Context Therapeutics Inc. (CNTX)'s trailing twelve month EV/EBITDA is -0.20x as of 2026-06-30.